Announced submission and validation of Marketing Authorization Application (MAA) submission to the European Medicines Agency (EMA) seeking marketing approval of DCCR (marketed in the U.S. as VYKAT XR) ...

New approach finds ‘parent-of-origin’ effects in more than a dozen genes — without the need for parental data.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the second quarter ended June 30, 2025.

Katie Price's son Harvey made fans emotional after his father celebrated his younger child's birthday and seemingly ignored ...

KATIE Price has opened up about an emotional week after eldest son Harvey finished college and moved to his new home in ...

We came across a bullish thesis on Harmony Biosciences Holdings, Inc. on In. Specter’s Substack. In this article, we will ...

Four years before Kimberly Gallagher enrolled in Medicaid herself, the public health insurance program’s rules prompted her ...

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

Conference Call Information Rhythm Pharmaceuticals will host a live conference call and webcast at 8:00 a.m. ET today to review its second quarter 2025 financial results and recent business activities ...

Discover key insights from Soleno Therapeutics' Q2 2025 earnings call, highlighting Vykat XR's strong launch, revenue growth, EU expansion efforts & ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13, 2025 at 2:30 p.m.

A bipartisan resolution in the Illinois Senate could bring more awareness and education to state schools that would increase the knowledge and understanding of students with special needs. The ...